Corvus Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Corvus Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2015 to Q4 2023.
  • Corvus Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $12.8M, a 0.81% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $12.8M +$103K +0.81% Dec 31, 2023 10-K 2024-03-19
Q4 2022 $12.7M +$216K +1.73% Dec 31, 2022 10-K 2024-03-19
Q4 2021 $12.5M +$347K +2.85% Dec 31, 2021 10-K 2024-03-19
Q4 2020 $12.2M +$10.3M +545% Dec 31, 2020 10-K 2024-03-19
Q4 2019 $1.89M +$81K +4.49% Dec 31, 2019 10-K 2023-03-28
Q4 2018 $1.8M +$585K +48% Dec 31, 2018 10-K 2022-03-10
Q4 2017 $1.22M +$615K +102% Dec 31, 2017 10-K 2021-03-25
Q4 2016 $604K +$469K +347% Dec 31, 2016 10-K 2020-03-09
Q4 2015 $135K Dec 31, 2015 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.